These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17711866)

  • 21. Disseminated tuberculosis secondary to adalimumab.
    Pednekar M; Chandra AB; Chandra PA
    Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
    Choi SR; Park JW; Lee EB; Park JK
    Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
    Greenberg JD; Reed G; Kremer JM; Tindall E; Kavanaugh A; Zheng C; Bishai W; Hochberg MC;
    Ann Rheum Dis; 2010 Feb; 69(2):380-6. PubMed ID: 19359261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.
    Hsia EC; Cush JJ; Matteson EL; Beutler A; Doyle MK; Hsu B; Xu S; Rahman MU
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):309-13. PubMed ID: 22782640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].
    La Montagna G; Tirri R; Vitello R; Malesci D; Buono R; Mennillo G; Valentini G
    Reumatismo; 2006; 58(4):261-7. PubMed ID: 17216014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
    J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.
    Benedek TG
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S3-8. PubMed ID: 21044425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
    Marchesoni A; Battafarano N; Arreghini M; Panni B; Gallazzi M; Tosi S
    Rheumatology (Oxford); 2003 Dec; 42(12):1545-9. PubMed ID: 12810924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pulmonological manifestations of rheumatoid arthritis].
    Bernscherer G; Karabélyos C; Tarján Z
    Orv Hetil; 2008 Jul; 149(29):1355-61. PubMed ID: 18617467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
    Verstappen SM; Bakker MF; Heurkens AH; van der Veen MJ; Kruize AA; Geurts MA; Bijlsma JW; Jacobs JW;
    Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F; Michaud K
    Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong--the role of TNF blockers in an area of high tuberculosis burden.
    Tam LS; Leung CC; Ying SK; Lee GK; Yim CW; Leung YY; Kun EW; Wong KK; Li EK
    Clin Exp Rheumatol; 2010; 28(5):679-85. PubMed ID: 20822708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
    Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Thompson AE; Rieder SW; Pope JE
    Arthritis Rheum; 2011 Jun; 63(6):1479-85. PubMed ID: 21360522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.